Jun 2, 2020 · Over 100 studies are under way to find a vaccine for COVID-19. Vaccination is one of the world’s most successful health interventions, saving as many as 3 million lives every year. But a further 1.5 million deaths a year could be avoided with improved global coverage. Cost, conflict and vaccine hesitancy are among the barriers.

Jan 31, 2022 · The large crowds gathered to protest COVID-19 vaccine mandates suggest hesitancy may be more common in Europe than survey results indicate, according to this piece – which traces some of the region’s anti-vaccination history. (Institut Montaigne)

Jun 8, 2021 · The world will need billions of COVID-19 vaccine doses. Around the world, there is a concerted effort under way to vaccinate as many people as possible against COVID-19, as quickly as possible. After slow starts in some countries, steady progress is now being made - although the rollout remains unequal .

Mar 13, 2023 · Since COVID-19 vaccines began to be rolled out in late 2020, more than 13 billion doses have been distributed around the world, but not evenly. Global leaders say 1.3 million lives could have been saved with more equitable global vaccine distribution in the first year of …

Jul 14, 2020 · The COVID-19 coronavirus crisis has wrought economic disruption on a monumental scale, contributing to a dangerous and volatile global upheaval – politically, socially and geopolitically – while raising deep concerns about the environment and the extending reach of technology into our lives.

Jan 6, 2021 · The richest nations have secured billions of doses of COVID-19 vaccines, while developing economies struggle to access supplies. Vaccine nationalism – where countries push to get first access – could slow the global economic recovery, costing high …

Newer methods take a more targeted approach. While RNA-based technology is used in some COVID-19 vaccines, others are viral vector versions that use DNA to trigger an immune response to coronavirus proteins (examples include the Johnson & Johnson COVID-19 vaccine recently authorized in the US).

Nov 20, 2020 · Tackling COVID-19 will require the first-ever deployment of blockchain in the global distribution of a vaccine. Blockchain offers an immutable, decentralized database that can help all parties be sure that vaccine supplies are being stored and handled properly.

Jul 29, 2021 · The COVID vaccine market is worth at least $150 billion. Can we stop it being flooded with fakes? As recently as 15 years ago, building a facility to produce biologics such as monoclonal antibodies or vaccines could require an investment of as much as €500m, and it would take up to 3 years to bring that facility online.

Dec 2, 2020 · The Access to COVID-19 Tools Accelerator (ACT-Accelerator) is the global collaboration to accelerate development, production, and equitable access to COVID-19 tests, treatments, and vaccines. It is the only instrument of its kind with principles of universal access and equity at its core.